INVO Fertility, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $2.4M
- Price
- $1.06
- % Change (Daily % change from the live per-ticker quote feed.)
- -7.83%
- Volume
- 419.0K
About
INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.
Quick stats
Shares outstanding2.3M
Computed float1.8M
Float / shares77.5%
Cash runway (months)9.5
Key info
SectorHealthcare
IndustryMedical - Devices
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001417926
AI Summary
AI-generated1/12
minorbullishoperations update
INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International
INVO Fertility announced that its Wisconsin Fertility Institute presented five poster abstracts at the 2026 Midwest Reproductive Symposium International, focusing on the efficacy of platelet-rich plasma (PRP) in treating poor IVF outcomes.
The retrospective studies, involving patient cohorts ranging from 9 to 19 individuals, reported improvements in ovarian response, embryo development, and endometrial thickness, with mean thickness increasing from 6.1 mm to 8.1 mm in one cohort.
Management views the presentations as validation of the clinical expertise within its expanding clinic platform and a step toward advancing its mission of expanding access to assisted reproductive technology.
Red flags
- small sample sizes in presented studies (n=9 to n=19)
- retrospective study design requires prospective confirmation